EUCTR2014-001538-28-FR进行中（未招募）1 期
/A - BREMEAVAC
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 70
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Study of TSR-022, a Monoclonal Antibody, in Patients with Advanced Solid TumorsPatients with Advanced Solid TumorsCTIS2023-507564-39-00Tesaro Inc.2,442
进行中（未招募）
1 期
/AMedDRA version: 19.1Level: PTClassification code 10061171Term: Gastrointestinal disorder postoperativeSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2014-001462-99-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)12
进行中（未招募）
1 期
/AMedDRA version: 14.1Level: PTClassification code 10038683Term: Respiratory disorderSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-005029-31-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)280
进行中（未招募）
1 期
A Phase 1 relative bioavailability study in 14 healthy adult participants investigating the Arvisol® tablets to see whether its pharmacokinetic properties are similar to the reference drug which is a marketed oral soliton cannabidiol, named Epidiolex® CBD oral solution.Healthy volunteersMedDRA version: 26.0Level: LLTClassification code: 10088820Term: Clinical trial healthy volunteer Class: 100000004848CTIS2023-509862-39-00Echo Pharmaceuticals B.V.14
进行中（未招募）
1 期
/AEUCTR2021-002174-52-FRAssistance Publique -Hopitaux de Paris400